# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Applied DNA Sciences (NASDAQ:APDN) reported quarterly losses of $(5.31) per share which missed the analyst consensus estimate o...
Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the Company), a leader in PCR-based DNA technologies, today announced ...
HC Wainwright & Co. analyst Yi Chen maintains Applied DNA Sciences (NASDAQ:APDN) with a Buy, adjusts target to $1.5 from...